The blockade of Lox enzyme activity in Lox/Loxl1+ mesenchymal cells could attenuate DSS colitis and reduce circulating markers of oxidative stress by reducing hydrogen peroxide (Kinchen et al., 2018). Here, LOX is linked to colitis.